NYSE

Kenvue Inc. (KVUE)

♄ 556 Thanks from members

Kenvue Inc. (KVUE) demonstrates resilient earnings, margin expansion, and consecutive quarters of organic sales growth, though tempered by modest volume gains, elevated debt, a pending Kimberly-Clark transaction, and enduring legal exposure from legacy talc products.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →